A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 diseaseSham Nambulli, W. Paul Duprex|Journal of Virology|2024Cited by 4